These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9157601

  • 1. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels.
    Vischer UM, Ingerslev J, Wollheim CB, Mestries JC, Tsakiris DA, Haefeli WE, Kruithof EK.
    Thromb Haemost; 1997 Feb; 77(2):387-93. PubMed ID: 9157601
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z.
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [Abstract] [Full Text] [Related]

  • 7. Small GTP-binding protein Ral is involved in cAMP-mediated release of von Willebrand factor from endothelial cells.
    Rondaij MG, Sellink E, Gijzen KA, ten Klooster JP, Hordijk PL, van Mourik JA, Voorberg J.
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1315-20. PubMed ID: 15130921
    [Abstract] [Full Text] [Related]

  • 8. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.
    Kaufmann JE, Oksche A, Wollheim CB, Günther G, Rosenthal W, Vischer UM.
    J Clin Invest; 2000 Jul; 106(1):107-16. PubMed ID: 10880054
    [Abstract] [Full Text] [Related]

  • 9. Von Willebrand factor propeptide in vascular disorders.
    van Mourik JA, Romani de Wit T.
    Thromb Haemost; 2001 Jul; 86(1):164-71. PubMed ID: 11487004
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma.
    Brown SA, Collins PW, Bowen DJ.
    Thromb Haemost; 2002 Jun; 87(6):990-6. PubMed ID: 12083507
    [Abstract] [Full Text] [Related]

  • 14. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK, Mestries JC, Gascon MP, Ythier A.
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
    Deitcher SR, Tuller J, Johnson JA.
    Haemophilia; 1999 Mar; 5(2):88-95. PubMed ID: 10215955
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.
    van Kesteren PJ, Kooistra T, Lansink M, van Kamp GJ, Asscheman H, Gooren LJ, Emeis JJ, Vischer UM, Stehouwer CD.
    Thromb Haemost; 1998 May; 79(5):1029-33. PubMed ID: 9609242
    [Abstract] [Full Text] [Related]

  • 19. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 May; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.